The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: APC vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000038.6(APC):c.1312+3A>G

CA279764

217924 (ClinVar)

Gene: APC
Condition: familial adenomatous polyposis 1
Inheritance Mode: Autosomal dominant inheritance
UUID: 668e53dc-c465-4363-aaf0-a326f0fc82b1
Approved on: 2025-05-15
Published on: 2025-05-19

HGVS expressions

NM_000038.6:c.1312+3A>G
NM_000038.6(APC):c.1312+3A>G
NC_000005.10:g.112819347A>G
CM000667.2:g.112819347A>G
NC_000005.9:g.112155044A>G
CM000667.1:g.112155044A>G
NC_000005.8:g.112182943A>G
NG_008481.4:g.131827A>G
ENST00000502371.3:c.1312+3A>G
ENST00000504915.3:c.1312+3A>G
ENST00000505084.2:n.1368+3A>G
ENST00000505350.2:c.*1318+3A>G
ENST00000507379.6:c.1258+3A>G
ENST00000509732.6:c.1312+3A>G
ENST00000512211.7:c.1312+3A>G
ENST00000257430.9:c.1312+3A>G
ENST00000257430.8:c.1312+3A>G
ENST00000507379.5:c.1258+3A>G
ENST00000508376.6:c.1312+3A>G
ENST00000508624.5:c.*634+3A>G
ENST00000512211.6:c.1312+3A>G
NM_000038.5:c.1312+3A>G
NM_001127510.2:c.1312+3A>G
NM_001127511.2:c.1258+3A>G
NM_001354895.1:c.1312+3A>G
NM_001354896.1:c.1312+3A>G
NM_001354897.1:c.1342+3A>G
NM_001354898.1:c.1237+3A>G
NM_001354899.1:c.1228+3A>G
NM_001354900.1:c.1135+3A>G
NM_001354901.1:c.1135+3A>G
NM_001354902.1:c.1039+3A>G
NM_001354903.1:c.1009+3A>G
NM_001354904.1:c.934+3A>G
NM_001354905.1:c.832+3A>G
NM_001354906.1:c.463+3A>G
NM_001127510.3:c.1312+3A>G
NM_001127511.3:c.1258+3A>G
NM_001354895.2:c.1312+3A>G
NM_001354896.2:c.1312+3A>G
NM_001354897.2:c.1342+3A>G
NM_001354898.2:c.1237+3A>G
NM_001354899.2:c.1228+3A>G
NM_001354900.2:c.1135+3A>G
NM_001354901.2:c.1135+3A>G
NM_001354902.2:c.1039+3A>G
NM_001354903.2:c.1009+3A>G
NM_001354904.2:c.934+3A>G
NM_001354905.2:c.832+3A>G
NM_001354906.2:c.463+3A>G
More

Pathogenic

Met criteria codes 4
PM2_Supporting PS2_Moderate PS3_Moderate PS4_Very Strong

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for APC Version 2.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP
The NM_000038.6(APC):c.1312+3A>G variant in APC is an intronic variant which is located at the 3rd nucleotide in intron 10. This variant has been reported in more than 16 cases meeting phenotypic criteria resulting in a total phenotype score of 16 points (internal data Labcorp Genetics [formerly Invitae], Peter MacCallum Cancer Centre, Victoria, Australia, GeneDx, Ambry; PMID: 8381580, 15459959, 20223039, 17489848, 19793053, 20685668) (PS4_Very Strong). This variant has been identified as a de novo occurrence with confirmed parental relationships in one individual with FAP, resulting in a total de novo score of 1 (PS2_Moderate, Ambry internal data). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). RNA studies demonstrated that the variant impacts splicing by causing exon 10 skipping (PMID: 15459959, Ambry internal data) (PS3_Moderate). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal-dominant inherited FAP based on the ACMG/AMP criteria applied, as specified by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP: criteria PS4_Very Strong, PS2_Moderate, PM2_Supporting, PS3_Moderate applied (VCEP specifications version v2.1.0; date of approval 11/24/2023).
Met criteria codes
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
PS2_Moderate
This variant has been identified as a de novo occurrence with confirmed parental relationships in one individual with FAP, resulting in a total de novo score of 1 (PS2_Moderate, Ambry internal data).
PS3_Moderate
RNA studies demonstrated that the variant impacts splicing by causing exon 10 skipping (PMID: 15459959, Ambry internal data) (PS3_Moderate).

PS4_Very Strong
This variant has been reported in more than 16 cases meeting phenotypic criteria resulting in a total phenotype score of 16 points (internal data Labcorp Genetics [formerly Invitae], Peter MacCallum Cancer Centre, Victoria, Australia, GeneDx, Ambry; PMID: 8381580, 15459959, 20223039, 17489848, 19793053, 20685668) (PS4_Very Strong).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.